Dr. Ramalingam Ratnasabapathy
Claim this profileComprehensive Cancer Centers of Nevada
Studies Non-Small Cell Lung Cancer
Studies Multiple Myeloma
3 reported clinical trials
6 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Stage III
Stage IV
EGFR positive
2Multiple Myeloma
Affiliated Hospitals
Clinical Trials Ramalingam Ratnasabapathy is currently running
Zipalertinib + Chemotherapy
for Non-Small Cell Lung Cancer
The purpose of this study is to evaluate the safety and efficacy of zipalertinib in combination with standard first-line platinum-based chemotherapy compared to chemotherapy alone, in patients with locally advanced or metastatic NSCLC with EGFR ex20ins mutations.
Recruiting2 awards Phase 313 criteria
CAB-AXL-ADC + PD-1 Inhibitor
for Lung Cancer
The objective of this study is to assess safety and efficacy of CAB-AXL-ADC in NSCLC
Recruiting1 award Phase 27 criteria
More about Ramalingam Ratnasabapathy
Clinical Trial Related1 year of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Ramalingam Ratnasabapathy has experience with
- Ixazomib
- Lenalidomide
- Dexamethasone
- CAB-AXL-ADC
- PD-1 Inhibitor
- Zipalertinib
Breakdown of trials Ramalingam Ratnasabapathy has run
Non-Small Cell Lung Cancer
Multiple Myeloma
Plasma Cell Neoplasms
Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ramalingam Ratnasabapathy specialize in?
Ramalingam Ratnasabapathy focuses on Non-Small Cell Lung Cancer and Multiple Myeloma. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage III patients, or patients who are Stage IV.
Is Ramalingam Ratnasabapathy currently recruiting for clinical trials?
Yes, Ramalingam Ratnasabapathy is currently recruiting for 2 clinical trials in Henderson Nevada. If you're interested in participating, you should apply.
Are there any treatments that Ramalingam Ratnasabapathy has studied deeply?
Yes, Ramalingam Ratnasabapathy has studied treatments such as Ixazomib, Lenalidomide, Dexamethasone.
What is the best way to schedule an appointment with Ramalingam Ratnasabapathy?
Apply for one of the trials that Ramalingam Ratnasabapathy is conducting.
What is the office address of Ramalingam Ratnasabapathy?
The office of Ramalingam Ratnasabapathy is located at: Comprehensive Cancer Centers of Nevada, Henderson, Nevada 89052 United States. This is the address for their practice at the Comprehensive Cancer Centers of Nevada.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.